| Pharmaceutical Information |
| Drug Name |
Framycetin |
| Drug ID |
BADD_D00975 |
| Description |
A component of neomycin that is produced by Streptomyces fradiae. On hydrolysis it yields neamine and neobiosamine B. (From Merck Index, 11th ed) |
| Indications and Usage |
For the treatment of bacterial blepharitis, bacterial bonjunctivitis, corneal injuries, corneal ulcers and meibomianitis. For the prophylaxis of ocular infections following foreign body removal |
| Marketing Status |
approved |
| ATC Code |
D09AA01; R01AX08; S01AA07 |
| DrugBank ID |
DB00452
|
| KEGG ID |
D05140
|
| MeSH ID |
D005601
|
| PubChem ID |
8378
|
| TTD Drug ID |
D05JNI
|
| NDC Product Code |
Not Available |
| UNII |
4BOC774388
|
| Synonyms |
Framycetin | Neomycin B | Antibiotic 10676 | Neomycin B Sulfate | Sulfate, Neomycin B | Framycetin Sulfate | Sulfate, Framycetin | Soframycin |
|
| Chemical Information |
| Molecular Formula |
C23H46N6O13 |
| CAS Registry Number |
119-04-0 |
| SMILES |
C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
